Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rossari Biotech informed stock exchanges that promoter Sunil Srinivasan Chari transferred 88 lakh equity shares (15.89% of total share capital) to other members of the promoter group by way of a gift on August 28, 2025, with no consideration involved. The shares went to Yash Sunil Chari (23 lakh shares, 4.15%), Jyotishna Sunil Chari (15 lakh shares, 2.71%), and the Chari Family Trust (50 lakh shares, 9.03%). The transfer was an off-market, inter-se family arrangement to streamline family assets, exempt under Regulation 10(1)(a)(ii) of SEBI SAST Regulations. Crucially, the aggregate promoter and promoter group holding in the company remains unchanged before and after this transfer. As a result of the transfer, Sunil Chari's individual stake reduced from 29.06% to 13.17%, while the Chari Family Trust's holding rose to 13.17%.
This is a purely internal family restructuring with no change in total promoter ownership, so it is unlikely to have any meaningful impact on the stock price. Existing shareholders are not affected since no new shares enter the market and the promoter group's overall control of the company is unchanged.